OM: A Protein That Regulates Histone Acetylation and Plays A Role in Disease Development

Target Name: OCM

NCBI ID: G654231

Content of Review Report on OCM Target / Biomarker

OCM

OM: A Protein That Regulates Histone Acetylation and Plays A Role in Disease Development

OCM, or O-Acetylmethionine, is a protein that is expressed in various tissues throughout the body. It is a key player in the regulation of gene expression and has been linked to a number of diseases, including cancer, neurodegenerative diseases, and mental disorders. As a drug target or biomarker, OCM has the potential to be a valuable tool in the development of new treatments for these conditions.

One of the key functions of OCM is its role in modulating the levels of histone acetylation, which is a post-translational modification that plays a critical role in the regulation of gene expression. Histone acetylation is the process by which histones, which are small proteins that make up the nuclei of eukaryotic cells, are modified with an acetyl group. This modification has a number of functions, including the regulation of gene expression, the maintenance of tissue structure and the regulation of cell signaling pathways.

OM has been shown to play a key role in the regulation of histone acetylation. It is a protein that is highly acetylated itself, and it has been shown to play a role in the transfer of the acetyl group from histones to other proteins. This process is known as histone acetylation, and it is a critical step in the regulation of gene expression.

OM has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of a number of diseases, including cancer, neurodegenerative diseases, and mental disorders. For example, OCM has been shown to be involved in the regulation of the expression of genes that are involved in cell growth, differentiation, and survival. It has also been shown to play a role in the regulation of cell signaling pathways, including the TGF-β pathway, which is involved in the regulation of cell growth and differentiation.

As a drug target or biomarker, OCM has the potential to be a valuable tool in the development of new treatments for a number of diseases. For example, it has been shown to be involved in the regulation of gene expression that is important for the development of cancer, and it has been shown to play a role in the regulation of cellular processes that are important for the development and progression of neurodegenerative diseases. By targeting OCM with drugs or other therapeutic agents, it may be possible to develop new treatments for these conditions.

Protein Name: Oncomodulin

Functions: Has some calmodulin-like activity with respect to enzyme activation and growth regulation. Binds two calcium ions

The "OCM Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OCM comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets